Click a link below to view the mailing archive as if it had been sent to you.
| 2017-02-28 12:15 | | Valeant touts Salix salesforce scale-up amid rumors of mass rep exit and more... |
| 2017-02-28 00:15 | | The world's biggest drugmaker just pulled back the curtain on drug pricing and more... |
| 2017-02-27 12:15 | | Physician-Rep Conversation - A Lesson From Cafepharma and more... |
| 2017-02-27 00:15 | | Top Biopharma Movers of the Past Week and more... |
| 2017-02-26 00:15 | | Pfizer subpoenaed in U.S. over patient assistance plans and more... |
| 2017-02-24 12:30 | | Roche confirms patient death in ACE910 PhIII hemophilia trial, spurring new questions about top blockbuster hopeful and more... |
| 2017-02-24 12:15 | | Roche confirms patient death in ACE910 PhIII hemophilia trial, spurring new questions about top blockbuster hopeful and more... |
| 2017-02-24 00:15 | | One more time: We're not buying Valeant, Allergan CEO insists and more... |
| 2017-02-23 12:15 | | Top 10 U.S. patent losses of 2017 and more... |
| 2017-02-23 00:15 | | Big Pharma CEOs push hard for tax reform and a proposed border levy and more... |
| 2017-02-22 12:15 | | 2016 went out like a lamb in the biopharma M&A world. Will it roar back in 2017? Plus, top 10 deals and more... |
| 2017-02-22 00:15 | | Icahn Takes Bristol-Myers Stake With M&A In Mind; Who Could Be The Acquirer? and more... |
| 2017-02-21 12:15 | | Pfizer shortens comeback campaign for armed antibody inotuzumab, lands quick FDA review and more... |
| 2017-02-20 12:15 | | Where are all the new diabetes drugs? and more... |
| 2017-02-20 00:15 | | With FDA nod, Biotronik debuts first coronary stent in U.S. and more... |
| 2017-02-19 00:15 | | Daiichi, ArQule cancer drug fails in late-stage study and more... |
| 2017-02-17 12:15 | | Sage Therapeutics Leads Biotech Movers on False Takeout Rumors and more... |
| 2017-02-17 00:15 | | Why This FDA Approval for Valeant Is Not as Good as First Thought and more... |
| 2017-02-16 12:15 | | The CRISPR patent decision: Your six takeaways and more... |
| 2017-02-16 00:15 | | Why medtech companies should implement regionalized sales models |
| 2017-02-15 12:15 | | Top 25 rare disease brands, by sales and more... |
| 2017-02-15 00:15 | | Merck stopping late stage study as another Alzheimer's drug fails and more... |
| 2017-02-14 12:15 | | Intercept cuts targets for pivotal NASH study and more... |
| 2017-02-14 00:15 | | The Most Innovative Biotech Companies of 2017 and more... |
| 2017-02-13 12:15 | | Allergan to buy Zeltiq Aesthetics for about $2.48 bln and more... |
| 2017-02-12 00:15 | | Earnings Preview: What To Expect From Teva Pharmaceutical On Monday and more... |
| 2017-02-11 00:15 | | Another US insurer places limits on Spinraza coverage and more... |
| 2017-02-10 12:15 | | Generic threat hangs over GlaxoSmithKline's Advair and more... |
| 2017-02-10 00:15 | | PBMs counter pharma's pricing blame with proposals to cut $100B in drug costs and more... |
| 2017-02-09 12:15 | | Regeneron revenue rises 11.7 pct on Eylea eye drug and more... |
| 2017-02-09 00:15 | | Tesaro shares skyrocket on report of buyout interest from drugmakers and more... |
| 2017-02-08 12:15 | | Drugmaker Sanofi sees weak 2017 earnings, not in hurry for M&A and more... |
| 2017-02-08 00:15 | | Gilead 2017 hepatitis C sales forecast disappoints, shares drop and more... |
| 2017-02-07 12:15 | | A swarm of top biotech execs protest against Trump’s travel ban, saying it threatens the entire industry and more... |
| 2017-02-07 00:15 | | Teva CEO out, board chairman steps in as interim chief and more... |
| 2017-02-06 12:15 | | Mylan: $5 Billion Potential Liability From EpiPen Underpayment Of CMS Rebates and more... |
| 2017-02-06 00:15 | | After promising Trump new US jobs, Eli Lilly sets out to chop 200 R&D staffers and more... |
| 2017-02-04 12:15 | | Pfizer's New Biosimilar Is Off and Running and more... |
| 2017-02-03 12:15 | | Pfizer Said to Hire JPMorgan to Weigh $2 Billion Portfolio Sale and more... |
| 2017-02-02 12:15 | | Merck's sales miss as Keytruda, diabetes drugs lag estimates and more... |
| 2017-02-02 00:15 | | Pfizer's Read sees positives for industry under Trump and more... |
| 2017-02-01 12:15 | | Biogen's hemophilia business spin-off will trade on its own starting Thursday and more... |
